Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
Clinical trial NCT07226661 · RECRUITING
Trial details
- NCT number
- NCT07226661
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2026-12-31
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.